Hafrun Fridriksdottir, Executive VP, Global R&D at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 20,297 shares at $12.14 ($246K) on 2020-02-14, disclosed to the SEC on 2020-02-18.
Open-market sale of $246k TEVA by Executive VP, Global R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.14 | 2,647 | $32K | 13.0% |
| 2 | $12.14 | 8,825 | $107K | 43.5% |
| 3 | $12.14 | 8,825 | $107K | 43.5% |
| Total | $12.14 avg | 20,297 | $246K | 100% |
| Filing → |
| TEVA | SELL | 2022-03-02 | $124K | — | Filing → |
| TEVA | SELL | 2022-02-10 | $111K | — | Filing → |
| TEVA | SELL | 2021-08-12 | $1.0M | — | Filing → |